celecoxib has been researched along with Hypertension, Portal in 3 studies
Hypertension, Portal: Abnormal increase of resistance to blood flow within the hepatic PORTAL SYSTEM, frequently seen in LIVER CIRRHOSIS and conditions with obstruction of the PORTAL VEIN.
| Excerpt | Relevance | Reference |
|---|---|---|
| " However, the links between low NO bioavailability and COX-2 overexpression in LSECs are unknown." | 1.62 | Celecoxib reduces hepatic vascular resistance in portal hypertension by amelioration of endothelial oxidative stress. ( Gao, J; Jia, X; Liu, R; Tai, Y; Tang, C; Tang, S; Tong, H; Zhang, L; Zhao, C, 2021) |
| "Celecoxib treatment greatly reduced the tortuous hepatic portal venules." | 1.39 | Celecoxib ameliorates portal hypertension of the cirrhotic rats through the dual inhibitory effects on the intrahepatic fibrosis and angiogenesis. ( Gao, JH; Huang, ZY; Liu, ZX; Lu, YY; Tang, CW; Tong, H; Wen, SL; Yang, WJ, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Tai, Y | 1 |
| Zhao, C | 1 |
| Zhang, L | 1 |
| Tang, S | 1 |
| Jia, X | 1 |
| Tong, H | 3 |
| Liu, R | 2 |
| Tang, C | 1 |
| Gao, J | 1 |
| Gao, JH | 2 |
| Wen, SL | 2 |
| Yang, WJ | 2 |
| Lu, YY | 2 |
| Huang, ZY | 2 |
| Liu, ZX | 1 |
| Tang, CW | 2 |
| Feng, S | 1 |
| Tang, SH | 1 |
| Tang, YM | 1 |
| Yang, JH | 1 |
| Xie, HQ | 1 |
3 other studies available for celecoxib and Hypertension, Portal
| Article | Year |
|---|---|
Celecoxib reduces hepatic vascular resistance in portal hypertension by amelioration of endothelial oxidative stress.
Topics: Animals; Antioxidants; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Disease Management; | 2021 |
Celecoxib ameliorates portal hypertension of the cirrhotic rats through the dual inhibitory effects on the intrahepatic fibrosis and angiogenesis.
Topics: Angiogenesis Inhibitors; Animals; Celecoxib; Disease Models, Animal; Hypertension, Portal; Kidney; L | 2013 |
Celecoxib and octreotide synergistically ameliorate portal hypertension via inhibition of angiogenesis in cirrhotic rats.
Topics: Angiogenesis Inhibitors; Animals; Celecoxib; Cyclooxygenase 2 Inhibitors; Drug Synergism; Hypertensi | 2016 |